Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Current Assets (2020 - 2021)

Historic Current Assets for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $395.3 million.

  • Design Therapeutics' Current Assets changed N/A to $395.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $395.3 million, marking a year-over-year change of. This contributed to the annual value of $36.2 million for FY2020, which is N/A changed from last year.
  • Per Design Therapeutics' latest filing, its Current Assets stood at $395.3 million for Q3 2021.
  • Design Therapeutics' Current Assets' 5-year high stood at $411.8 million during Q1 2021, with a 5-year trough of $36.2 million in Q4 2020.